Component of red wine may reduce risk of alcohol-related head and neck cancer
the ONA take:
According to a new study in the journal Advances in Experimental Medicine and Biology, researchers at the University of Colorado in Denver, Colorado, have found that resveratrol, a chemical found in grape skins and red wine, may prevent cancer.
Alcohol attacks a person's gene, and for a period of time, the body repairs this damage. When enough alcohol is consume, some DNA damage is no longer repaired, and it is for this reason that alcohol is a risk factor for head and neck cancer. Resveratrol kills these unfixed cells with DNA damage so that they cannot progress to cause cancer.
The body metabolizes alcohol into an intermediate called acetyl aldehyde before converting it to aldehyde dehydrogenase and ultimately acetic acid, which is excreted. Acetyl aldehyde is a known carcinogen.
Hard alcohol increases the risk for head and neck cancer due to the increased level of acetyl aldehyde, but this increased risk is lower among patients who drank red wine, suggesting that there is a component of red wine that inhibits the cancer-causing effect of alcohol.
That component is resveratrol. This substance will not completely reverse the cancer-causing effects of alcohol, but it may reduce the risk for alcohol use to lead to cancer.
Resveratrol, a chemical found in grape skins and red wine, may prevent cancer.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Integrative Medicine in Childhood Cancer: Practices That Can Help Pediatric Patients
- Patients and Caregivers Worry About Cost of Cancer Care
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Seeking an Explanation for the Lack of Research Focused in Pediatric Oncology Therapeutics
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
- G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
- Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
- The Effect of Intravenous Hydration Strategy on Plasma Methotrexate Clearance During Intravenous High-dose Methotrexate Administration in Pediatric Oncology Patients
- Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|